Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysis

Footnotes

Funding: This article has no funding source.

Conflicts of interest: The authors have no conflicts of interest to declare.

Institutional Review Board approval: Exempt.

Reprint requests: Richard J. Straker III

Portions of this data were presented as an oral presentation in the patient population research category at the 2021 Society of Investigative Dermatology Virtual Meeting on May 6, 2021.

Attachments: JAAD general submission checklist, research protocol and statistical analysis plan

留言 (0)

沒有登入
gif